Patterson Companies, Inc. (NASDAQ:PDCO) Shares Acquired by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. lifted its holdings in shares of Patterson Companies, Inc. (NASDAQ:PDCO) by 15.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,999 shares of the company’s stock after purchasing an additional 1,045 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Patterson Companies were worth $247,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in PDCO. GAMMA Investing LLC raised its holdings in Patterson Companies by 103.0% in the fourth quarter. GAMMA Investing LLC now owns 1,340 shares of the company’s stock valued at $41,000 after acquiring an additional 680 shares in the last quarter. Anchor Investment Management LLC lifted its position in shares of Patterson Companies by 20.5% during the 3rd quarter. Anchor Investment Management LLC now owns 2,350 shares of the company’s stock worth $51,000 after buying an additional 400 shares during the last quarter. KBC Group NV boosted its holdings in shares of Patterson Companies by 32.7% in the 3rd quarter. KBC Group NV now owns 2,757 shares of the company’s stock valued at $60,000 after buying an additional 680 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new position in shares of Patterson Companies in the 3rd quarter valued at $65,000. Finally, Blue Trust Inc. raised its stake in Patterson Companies by 18.0% during the 4th quarter. Blue Trust Inc. now owns 2,738 shares of the company’s stock worth $84,000 after acquiring an additional 417 shares in the last quarter. Institutional investors and hedge funds own 85.43% of the company’s stock.

Patterson Companies Trading Down 0.1 %

Shares of PDCO opened at $31.16 on Friday. The stock has a fifty day moving average of $31.04 and a two-hundred day moving average of $26.20. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.76 and a current ratio of 1.37. The company has a market capitalization of $2.76 billion, a PE ratio of 18.22, a price-to-earnings-growth ratio of 2.71 and a beta of 0.99. Patterson Companies, Inc. has a fifty-two week low of $19.45 and a fifty-two week high of $31.79.

Analysts Set New Price Targets

A number of analysts have recently commented on PDCO shares. Stifel Nicolaus cut their target price on Patterson Companies from $25.00 to $24.00 and set a “hold” rating on the stock in a research report on Thursday, December 5th. Leerink Partners reiterated a “market perform” rating and set a $31.35 target price (up previously from $29.00) on shares of Patterson Companies in a research report on Wednesday, December 11th. Piper Sandler cut their target price on Patterson Companies from $26.00 to $24.00 and set a “neutral” rating on the stock in a research report on Friday, December 6th. Leerink Partnrs cut Patterson Companies from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Finally, Robert W. Baird lifted their price objective on Patterson Companies from $25.00 to $31.00 and gave the company a “neutral” rating in a report on Thursday, December 12th. Eleven analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $26.57.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.